Efficacy and safety of tofacitinib for moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials
Journal of the European Academy of Dermatology and Venereology | Nov 19, 2017
|Most read this week
Journal of the European Academy of Dermatology and Venereology | Nov 19, 2017
|